Kobuchi S

References (6)

Title : Assessment of drug-drug interaction and optimization in capecitabine and irinotecan combination regimen using a physiologically based pharmacokinetic model - Sakai_2021_J.Pharm.Sci__
Author(s) : Sakai S , Kobuchi S , Ito Y , Sakaeda T
Ref : J Pharm Sci , : , 2021
Abstract :
PubMedSearch : Sakai_2021_J.Pharm.Sci__
PubMedID: 34965386

Title : Assessment of drug-drug interaction and optimization in capecitabine and irinotecan combination regimen using a physiologically based pharmacokinetic model - Sakai_2021_J.Pharm.Sci__
Author(s) : Sakai S , Kobuchi S , Ito Y , Sakaeda T
Ref : J Pharm Sci , : , 2021
Abstract :
PubMedSearch : Sakai_2021_J.Pharm.Sci__
PubMedID: 34965386

Title : Assessment of drug-drug interaction and optimization in capecitabine and irinotecan combination regimen using a physiologically based pharmacokinetic model - Sakai_2021_J.Pharm.Sci__
Author(s) : Sakai S , Kobuchi S , Ito Y , Sakaeda T
Ref : J Pharm Sci , : , 2021
Abstract :
PubMedSearch : Sakai_2021_J.Pharm.Sci__
PubMedID: 34965386

Title : Assessment of pharmacokinetic variations of capecitabine after multiple administration in rats: a physiologically based pharmacokinetic model - Sakai_2020_Cancer.Chemother.Pharmacol__
Author(s) : Sakai S , Kobuchi S , Ito Y , Sakaeda T
Ref : Cancer Chemother Pharmacol , : , 2020
Abstract :
PubMedSearch : Sakai_2020_Cancer.Chemother.Pharmacol__
PubMedID: 32240335

Title : Assessment of pharmacokinetic variations of capecitabine after multiple administration in rats: a physiologically based pharmacokinetic model - Sakai_2020_Cancer.Chemother.Pharmacol__
Author(s) : Sakai S , Kobuchi S , Ito Y , Sakaeda T
Ref : Cancer Chemother Pharmacol , : , 2020
Abstract :
PubMedSearch : Sakai_2020_Cancer.Chemother.Pharmacol__
PubMedID: 32240335

Title : Assessment of pharmacokinetic variations of capecitabine after multiple administration in rats: a physiologically based pharmacokinetic model - Sakai_2020_Cancer.Chemother.Pharmacol__
Author(s) : Sakai S , Kobuchi S , Ito Y , Sakaeda T
Ref : Cancer Chemother Pharmacol , : , 2020
Abstract :
PubMedSearch : Sakai_2020_Cancer.Chemother.Pharmacol__
PubMedID: 32240335